title: Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.
authors.affiliation: Department of Epidemiology, University of Texas M. D. Anderson Cancer Center, Houston, USA.
authors.forename: X
authors.initials: X
authors.lastname: Wu
authors.forename: H
authors.initials: H
authors.lastname: Yu
authors.forename: C I
authors.initials: CI
authors.lastname: Amos
authors.forename: W K
authors.initials: WK
authors.lastname: Hong
authors.forename: M R
authors.initials: MR
authors.lastname: Spitz
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D001580:Benzopyrenes; D001761:Bleomycin / Q000494:pharmacology; D016022:Case-Control Studies; D002478:Cells, Cultured; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis; D007335:Insulin-Like Growth Factor II / Q000096:biosynthesis; D008175:Lung Neoplasms / Q000378:metabolism*; D009153:Mutagens; D016017:Odds Ratio; D012307:Risk Factors; D013002:Somatomedins / Q000096:biosynthesis*
chemical_list: D000903:Antibiotics, Antineoplastic; D001580:Benzopyrenes; D018972:Insulin-Like Growth Factor Binding Protein 3; D009153:Mutagens; D013002:Somatomedins; D001761:Bleomycin; C072019:benzo(a)pyrene diolepoxide I; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II